Where Las Vegas comes to talk!

On Air Now: America's Morning News

health-news-page-header

Medical tech firm Becton Dickinson to buy C.R. Bard for $24B

FRANKLIN LAKES, N.J. (AP) — Medical technology firm Becton, Dickinson and Co. says it has reached an agreement to buy competitor C.R. Bard Inc. in a cash-and-stock deal worth $24 billion….

Trump Health Dept. dismisses Obama appointed surgeon general

WASHINGTON (AP) — The Trump administration has relieved Dr. Vivek Murthy of his duties as U.S. Surgeon General….

Possible shutdown, health care quagmire awaiting Congress

WASHINGTON (AP) — Lawmakers returning to Washington this coming week will find a familiar quagmire on health care legislation and a budget deadline dramatized by the prospect of a protracted battle between President Donald Trump and Democrats over his border wall….

Coal-state lawmakers push to extend retired miners’ benefits

WASHINGTON (AP) — Lawmakers from coal-mining states are pushing to extend health benefits for more than 22,000 retired miners and widows whose medical coverage is set to expire at the end of April….

FDA approves 2nd near-copy of Remicade for immune disorders

Federal regulators on Friday approved another alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders….

FDA approves near-copy of Remicade for immune disorders

Federal regulators have approved an alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders….

Italy upholds vaccine requirements for preschoolers

ROME (AP) — Italy's top administrative body has rejected a challenge to mandatory vaccines for children attending preschool….

Future of revamped health care bill remains dubious in House

WASHINGTON (AP) — Eager for a victory, the White House is expressing confidence that a breakthrough on the mired Republican health care bill could emerge in the House next week. The chamber's GOP leaders, burned by a March debacle, are dubious and signs are scant that an emerging plan is gaining enough votes to succeed….